| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |